Publicaciones (36) Publicaciones de ANA ISABEL TERLEIRA FERNÁNDEZ

2022

  1. Against All Odds? Addiction History Associated with Better Viral Hepatitis Care: A Dutch Nationwide Claims Data Study

    Journal of Clinical Medicine, Vol. 11, Núm. 4

  2. Carisoprodol Single and Multiple Dose PK-PD. Part II: Pharmacodynamics Evaluation Method for Central Muscle Relaxants. Double-Blind Placebo-Controlled Clinical Trial in Healthy Volunteers

    Journal of Clinical Medicine, Vol. 11, Núm. 4

2021

  1. Combination of Tocilizumab and Steroids to Improve Mortality in Patients with Severe COVID-19 Infection: A Spanish, Multicenter, Cohort Study

    Infectious Diseases and Therapy, Vol. 10, Núm. 1, pp. 347-362

2020

  1. Effect of enantiomerism on the bioequivalence of a new ibuprofen 600-mg tablet formulation obtained by roller compaction

    Chirality, Vol. 32, Núm. 2, pp. 185-190

2019

  1. Effect of Roux-en-Y gastric surgery on ciprofloxacin pharmacokinetics: an obvious effect?

    European Journal of Clinical Pharmacology, Vol. 75, Núm. 5, pp. 647-654

2018

  1. Interacciones de los fármacos con otros fármacos, con alimentos y con pruebas de laboratorio

    Velázquez. Farmacología básica y clínica (Editorial Médica Panamericana), pp. 1013-1021

  2. Reacciones adversas a los medicamentos

    Velázquez. Farmacología básica y clínica (Editorial Médica Panamericana), pp. 1115-1129

2014

  1. Direct oral anticoagulants in the treatment of acute venous thromboembolism: A systematic review and meta-analysis

    Thrombosis Research, Vol. 134, Núm. 4, pp. 774-782

  2. Pharmacoeconomic Evaluation of Dabigatran, Rivaroxaban and Apixaban versus Enoxaparin for the Prevention of Venous Thromboembolism After Total Hip or Knee Replacement in Spain

    PharmacoEconomics, Vol. 32, Núm. 9, pp. 919-936

  3. Specific antidotes in development for reversal of novel anticoagulants: A review

    Recent Patents on Cardiovascular Drug Discovery, Vol. 9, Núm. 1, pp. 2-10

2013

  1. Potential role of new anticoagulants for prevention and treatment of venous thromboembolism in cancer patients.

    Vascular health and risk management, Vol. 9, pp. 207-228

2012

  1. Dabigatran, rivaroxaban, or apixaban versus enoxaparin for thromboprophylaxis after total hip or knee replacement: Systematic review, meta-analysis, and indirect treatment comparisons

    BMJ (Online), Vol. 344, Núm. 7863

  2. Discovery of anticoagulant drugs: A historical perspective

    Current Drug Discovery Technologies, Vol. 9, Núm. 2, pp. 83-104

2010

  1. Better sexual acceptability of agomelatine (25 and 50 mg) compared with paroxetine (20 mg) in healthy male volunteers. An 8-week, placebo-controlled study using the PRSEXDQ-SALSEX scale

    Journal of Psychopharmacology, Vol. 24, Núm. 1, pp. 111-120

2009

  1. Estudio piloto de utilizaeión de antifúngieos sistémieos en el Hospital Clínieo San Carlos. Propuesta de un método de estudio

    Revista Espanola de Quimioterapia, Vol. 22, Núm. 3, pp. 127-134

2007

  1. Effect of drug-test interactions on length of hospital stay

    Pharmacoepidemiology and Drug Safety, Vol. 16, Núm. 1, pp. 39-45

2006

  1. Effects of Hypericum perforation on ivabradine pharmacokinetics in healthy volunteers: An open-label, pharmacokinetic interaction clinical trial

    Journal of Clinical Pharmacology, Vol. 46, Núm. 10, pp. 1188-1194

  2. Lack of pharmacokinetic interaction between omeprazole or lansoprazole and ivabradine in healthy volunteers: An open-label, randomized, crossover, pharmacokinetic interaction clinical trial

    Journal of Clinical Pharmacology, Vol. 46, Núm. 10, pp. 1195-1203

2005

  1. Bioequivalence study of two different tablet formulations of carvedilol in healthy volunteers

    Arzneimittel-Forschung/Drug Research, Vol. 55, Núm. 4, pp. 212-217

  2. Comparative bioavailability/bioequivalence of two different sertraline formulations: A randomised, 2-period × 2-sequence, crossover clinical trial in healthy volunteers

    Arzneimittel-Forschung/Drug Research, Vol. 55, Núm. 4, pp. 191-197